Thrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis.

Ranganathan, Usha; Kaunzner, Ulrike; Foster, Stacyann; Vartanian, Timothy; Perumal, Jai S

Ranganathan, Usha; Kaunzner, Ulrike; Foster, Stacyann; Vartanian, Timothy; Perumal, Jai S.

Afiliação

Ranganathan U; Department of Neurology, Weill Cornell Medical College, New York, NY, USA.
Kaunzner U; Department of Neurology, Weill Cornell Medical College, New York, NY, USA.
Foster S; Department of Neurology, Weill Cornell Medical College, New York, NY, USA.
Vartanian T; Department of Neurology, Weill Cornell Medical College, New York, NY, USA.
Perumal JS; Department of Neurology, Weill Cornell Medical College, New York, NY, USA.

Mult Scler ; 24(4): 553-554, 2018 04.

Article em En | MEDLINE | ID: mdl-28661221

Assuntos

Esclerose Múltipla Recidivante-Remitente; Esclerose Múltipla; Trombocitopenia; Alemtuzumab; Humanos; Interferon beta

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Limite: Humans Idioma: En Revista: Mult Scler Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google